Dr. Hayward directs the U-M National Clinician Scholars Program at the Institute for Healthcare Policy and Innovation (IHPI). He received his training in epidemiology, biostatistics, and health economics as a Robert Wood Johnson Clinical Scholar at the University of California Los Angeles (UCLA) and at the RAND Corporation in Santa Monica, California. His current and past work examines prediction of cardiovascular risk; decision analysis for the treatment of hypertension, diabetes, and hyperlipidemia; measurement of quality, costs and health status; and statistical and epidemiological nuances in the interpretation of clinical trials and in the development of clinical practice guidelines. Dr. Hayward has expertise in simulation modeling and clinical trial design particularly for Cardiovascular disease (CVD). Dr. Hayward and Dr. Sussman helped develop the Michigan Cardiovascular Dementia Model that will be refined and extended to apply to the stroke survivor population and include post-stroke cognitive and CVD outcomes. For the past five years, he has directed the Methods and Measurement Core of the Michigan Center for Diabetes Translational Research. In that role, he directs a biweekly seminar for junior faculty engaged in T2 and T3 translational research. The seminar is designed to help guide faculty from new faculty status to their K-award and thereafter to their first major R-award or equivalent.